These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 179712

  • 1. Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.
    Cox PJ, Phillips BJ, Thomas P.
    Cancer Treat Rep; 1976 Apr; 60(4):321-6. PubMed ID: 179712
    [Abstract] [Full Text] [Related]

  • 2. The enzymatic basis of the selective action of cyclophosphamide.
    Cox PJ, Phillips BJ, Thomas P.
    Cancer Res; 1975 Dec; 35(12):3755-61. PubMed ID: 172233
    [Abstract] [Full Text] [Related]

  • 3. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM, Wodinsky I, Myles A.
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [Abstract] [Full Text] [Related]

  • 4. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
    Brock N.
    Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205
    [Abstract] [Full Text] [Related]

  • 5. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
    Kohn FR, Landkamer GJ, Manthey CL, Ramsay NK, Sladek NE.
    Cancer Res; 1987 Jun 15; 47(12):3180-5. PubMed ID: 3034402
    [Abstract] [Full Text] [Related]

  • 6. Half-life of oxazaphosphorines in biological fluids.
    Sladek NE, Powers JF, Grage GM.
    Drug Metab Dispos; 1984 Jun 15; 12(5):553-9. PubMed ID: 6149904
    [Abstract] [Full Text] [Related]

  • 7. Identification of the mouse aldehyde dehydrogenases important in aldophosphamide detoxification.
    Manthey CL, Landkamer GJ, Sladek NE.
    Cancer Res; 1990 Aug 15; 50(16):4991-5002. PubMed ID: 2379164
    [Abstract] [Full Text] [Related]

  • 8. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K.
    Cancer Res; 1985 Sep 15; 45(9):4237-43. PubMed ID: 4028012
    [Abstract] [Full Text] [Related]

  • 9. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK, Waxman DJ.
    Cancer Res; 1993 Jun 01; 53(11):2490-7. PubMed ID: 8495410
    [Abstract] [Full Text] [Related]

  • 10. Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo.
    Voelcker G, Wagner T, Hohorst HJ.
    Cancer Treat Rep; 1976 Apr 01; 60(4):415-22. PubMed ID: 1277216
    [Abstract] [Full Text] [Related]

  • 11. Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
    Kwon CH, Maddison K, LoCastro L, Borch RF.
    Cancer Res; 1987 Mar 15; 47(6):1505-8. PubMed ID: 3815352
    [Abstract] [Full Text] [Related]

  • 12. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
    Yu LJ, Drewes P, Gustafsson K, Brain EG, Hecht JE, Waxman DJ.
    J Pharmacol Exp Ther; 1999 Mar 15; 288(3):928-37. PubMed ID: 10027828
    [Abstract] [Full Text] [Related]

  • 13. The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.
    Hohorst HJ, Draeger U, Peter G, Voelcker G.
    Cancer Treat Rep; 1976 Apr 15; 60(4):309-15. PubMed ID: 1277206
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines.
    Kohn FR, Sladek NE.
    Biochem Pharmacol; 1985 Oct 01; 34(19):3465-71. PubMed ID: 2996550
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aldophosphamide: synthesis, characterization, and comparison with "Hohorst's aldophosphamide".
    Struck RF.
    Cancer Treat Rep; 1976 Apr 01; 60(4):317-9. PubMed ID: 1277207
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.